Navigation Links
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
Date:9/21/2008

Patients show significant improvement through 2-year follow-up

MENLO PARK, Calif., Sept. 22 /PRNewswire/ -- Two multicenter studies published this week in Otolaryngology - Head and Neck Surgery confirm Balloon Sinuplasty(TM) technology is safe and effective when used by physicians to treat chronic sinusitis patients.

The foundation for those studies was a six-month clinical trial called CLEAR that began in 2005. It included 109 patients who had minimally invasive sinus surgery with the Balloon Sinuplasty(TM) technology. They participated in one-year and two-year follow-up studies which reported:

-- 92% functional patency at one-year follow-up.

-- At two-year follow-up, 85% of patients reported improvement in their

sinus symptoms. No patient's condition worsened.

-- Clinically and statistically significant improvements in patient

quality of life maintained at one and two year follow-up.

-- No serious adverse events observed at any time point throughout the

study.

Balloon Sinuplasty(TM) technology is used to restore normal sinus drainage by widening constricted sinus passages with specially designed catheters and balloons. The technology has been used to treat over 40,000 patients since receiving FDA clearance in 2005 and can be used alone or with standard surgical instrumentation.

The Center for Disease Control data reports sinusitis is among the most common illnesses in the U.S., affecting an estimated 37 million Americans and leading to 500,000 surgeries a year. Symptoms include repeated infections, headaches, facial pain, persistent congestion and unrelenting fatigue.

"The goal of sinus surgery is to open the sinuses so they can function normally, while preserving as much natural anatomy as possible. With Balloon Sinuplasty(TM) technology, we are able to accomplish that goal with our current approach in a true minimally invasive way, and give our patients the r
'/>"/>

SOURCE Acclarent, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
2. Most Cancer Treatment Studies Arent Published, Study Finds
3. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
4. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
5. Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
6. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
7. Genmab Announces Upcoming Ofatumumab Studies
8. Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
9. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
10. Treatment Corrects Severe Insulin Imbalance in Animal Studies
11. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... SCOLR Pharma, Inc. (Amex...three and nine months ended September 30, 2009. ...and CEO, said, "We continue to advance discussions...ation. Several potential partners have committed s...al resources as they evaluate the potential commer...
(Date:11/6/2009)...wswire-FirstCall/ -- Recession in domestic and int...Allied Healthcare Products in the first quarter of... Sales declines pushed Allied into a loss for the ...745,000, or negative 9 cents per share, compared t... or 3 cents per share. ,, Sales fell about 21 ...
(Date:11/6/2009)... 6 DUSA Pharmaceuticals,...pany that is developing and marketing Levulan(...focused on patients with common skin conditions, a...tive Officer, will present a corporate overview at...Tuesday, November 10, 2009 at 10:00 a.m. ET at the...
Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 1VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 2VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 3VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 4New old drug fights colon cancer 59359 1New old drug fights colon cancer 59359 2NIH awards more than 2454 Million to Kaiser Permanente to conduct health research 59355 1NIH awards more than 2454 Million to Kaiser Permanente to conduct health research 59355 2
...udies examining the effects of stem cell source an...s will be explored at a press conference taking pl...e 50th Annual Meeting of the American Society of H...s from a study examining a specialized technique f...lood for transplantation will also be shared durin...
...y assessing the quality of care for patients with ...ngs will be presented at a press conference on Sat...nnual Meeting of the American Society of Hematolog...ning methods that help determine stroke risk in ch...y examining the effects of long-term hydroxyurea u...
Other Medicine Technology:Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 2Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 3Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 4Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 5Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 6Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 7Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 8Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 2Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 3Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 4Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 5Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 6Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 7Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 8Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 9
(Date:11/8/2009)...PRNewswire-USNewswire/ -- Speaker Nancy Pelosi and...ing the House passage of H.R. 3962, the Affordable...a vote of 220 to 215. Below are the Speaker,s ope...just received a call from the President of the Uni...reat victory for the American people. I thank the ...
(Date:11/8/2009)...3D Global Solutions is pleased to announce that it...sal effort for ReSound who recently received an aw...tract. The award includes not only the Veterans Ad...nd other federal agencies. , ...obal Solutions is pleased to announce that it has ...
(Date:11/8/2009)...A jury of 8 people in the Western District of Penn...n pain and suffering for a medical malpractice cas...icia Nocera of Thomas E. Crenney and Associates, L...ta Monestersky and against the Uniontown Hospital....al hysterectomy at age 18. , ...
(Date:11/8/2009)...twork of Hispanic health advocates committed to ac..., WASHINGTON, Nov. 7 "...hey have heard the voice of America,s families by .... Now the Senate must deliver, without delay, on t... Dr. Jane L. Delgado, President and CEO of the Nat...
(Date:11/8/2009)...sage of H.R. 3961 to Secure the Stability of Medic... -- Statement Attributable to: J. James Rohack, M.... (Logo: http://www.newscom.com/cgi-bin/prnh/2008...of the House health reform bill, which will help i...ns and calls for swift passage of H.R. 3961 to sec...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
...gh School Raises More than $17,000 and Beats S... Cystic Fibrosis Foundation announced today that C...it Vestavia Hills High School in Birmingham, Ala.,...,000 for the CureFinders (R) program for the 20...
...Ovarian Cancer Coalition Says Gynecologic Health E... Factors , , DALLAS, May 5 At Mother,s Day, a ne...n (NOCC), www.ovarian.org , reveals some startl...g or skipping their annual gynecological exams alt...
...Experienced Law Firm Provides Informational Resour... Houston, TX (PRWEB) May 5, 2009 -- In res... loss products, Williams Kherkher has taken action...each efforts, it has launched an online resource c...
...May 5 Increased public and private expenditure on...ical insurance coverage and continued foreign dono...or growth within the Kenyan healthcare industry. T...enforcement. , , (Logo: http://www.newscom.com/...
...Sweden Tops List, Niger Ranks Last, United States ... Westport, Conn. (Vocus) May 5, 2009 -...es to be a mother, while sub-Saharan African count...organization,s State of the World,s Mothers 2009 ...
...prescription supply for $10 via free mail delivery... , , BENTONVILLE, Ark., May 5 Today in Michigan...r a 90-day supply of 300 generic prescriptions, ea...age of this new affordable pharmacy program from W...
Other Medicine News:Health News:CW's 7th Heaven Actress Mackenzie Rosman to Visit Birmingham Area High School to Honor Cystic Fibrosis Foundation Fundraising 2Health News:Women's Gynecological Exams: Another Victim of the Troubled Economy? 2Health News:Williams Kherkher Warns of Liver Damage, Failure from Hydroxycut 2Health News:Higher Outlays and Improved Regulatory Enforcement Create Opportunities in the Kenyan Healthcare Industry, Reveals Frost & Sullivan 2Health News:Higher Outlays and Improved Regulatory Enforcement Create Opportunities in the Kenyan Healthcare Industry, Reveals Frost & Sullivan 3Health News:A Mother's Report Card: The Best - and Worst - Countries for Mothers 2Health News:A Mother's Report Card: The Best - and Worst - Countries for Mothers 3Health News:New Walmart Program Broadens Access to Affordable Prescriptions in Michigan 2Health News:New Walmart Program Broadens Access to Affordable Prescriptions in Michigan 3
Lempert Bone Rongeurs Curved
Horsley Bulldog Bone Rongeur
Stille-Luer Bone Rongeurs
Ruskin Double Action Bone Rongeur Heavy Model
Medicine Products: